LEGRAND financials
LEGRAND
Country: FR Reporting currency: EUR Latest annual report: 2025-12-31
LEI:
969500XXRPGD7HCAFA90 Financial statements
(EUR, as reported — unscaled; 97 line items across 2 annual periods)
| Line item | 2025 | 2024 |
|---|---|---|
| Income statement | ||
| Revenue | €9.48B | €8.65B |
| Cost of sales | €4.66B | €4.18B |
| Operating profit (EBIT) | €1.81B | €1.64B |
| Net finance income / (cost) | -€117.4M | -€64.8M |
| Finance costs | €167.9M | €153.9M |
| Profit before tax | €1.69B | €1.58B |
| Income tax expense | €438.8M | €409.0M |
| Profit for the year | €1.25B | €1.17B |
| — attributable to owners | €1.24B | €1.17B |
| — attributable to NCI | €7.7M | €2.5M |
| Total comprehensive income | €544.8M | €1.42B |
| Per share | ||
| Basic EPS | €4.75 | €4.45 |
| Diluted EPS | €4.71 | €4.42 |
| Cash flow statement | ||
| Net cash from operating activities | €1.58B | €1.52B |
| Net cash from investing activities | -€1.61B | -€1.74B |
| Net cash from financing activities | €393.7M | -€535.8M |
| Dividends paid | €576.0M | €547.0M |
| Lease liability payments | €87.1M | €80.0M |
| Balance sheet | ||
| Total assets | €17.59B | €16.07B |
| Non-current assets | €12.02B | €11.11B |
| Property, plant & equipment | €970.9M | €913.8M |
| Right-of-use assets | €410.3M | €294.9M |
| Intangible assets & goodwill | €7.63B | €6.90B |
| Current assets | €5.57B | €4.96B |
| Inventories | €1.47B | €1.32B |
| Trade & other receivables | €1.23B | €1.05B |
| Cash & equivalents | €2.38B | €2.08B |
| Total equity | €7.33B | €7.55B |
| — attributable to owners | €7.29B | €7.53B |
| Non-controlling interests | €39.8M | €17.7M |
| Non-current liabilities | €7.37B | €5.95B |
| Long-term borrowings | €6.06B | €4.64B |
| Current liabilities | €2.88B | €2.58B |
| Short-term borrowings | €544.5M | €443.5M |
| Deferred tax liabilities | €1.01B | €1.00B |
| Derived metrics | ||
| Operating margin | 19.1% | 19.0% |
| Net margin | 13.2% | 13.5% |
| Return on equity | 17.1% | 15.5% |
| Cash conversion ratio | 1.26× | 1.30× |
| Other reported items | ||
| Adjustments For Decrease Increase In Inventories | -€137.4M | -€56.5M |
| Adjustments For Decrease Increase In Trade Account Receivable | -€120.4M | €11.4M |
| Adjustments For Impairment Loss Recognised In Profit Or Loss Goodwill | €0 | €0 |
| Adjustments For Increase Decrease In Trade Account Payable | €63.8M | -€11.7M |
| Adjustments For Interest Expense | €6.1M | €5.2M |
| Adjustments For Losses Gains On Disposal of Noncurrent Assets | €4.4M | €1.4M |
| Adjustments For Undistributed Profits of Investments Accounted For Using Equity Method | €0 | €0 |
| Adjustments For Unrealised Foreign Exchange Losses Gains | €1.0M | €100.0K |
| Cancellation of Treasury Shares | €0 | -€160.0M |
| Cash Flows From Used In Increase Decrease In Current Borrowings | -€330.0M | -€613.9M |
| Cash Flows Used In Obtaining Control of Subsidiaries Or Other Businesses Classified As Investing Activities | €1.31B | €1.51B |
| Comprehensive Income Attributable To Noncontrolling Interests | €7.6M | €1.0M |
| Comprehensive Income Attributable To Owners of Parent | €537.2M | €1.42B |
| Current Provisions | €162.1M | €178.1M |
| Current Tax Assets | €158.9M | €212.5M |
| Current Tax Liabilities | €55.3M | €48.1M |
| Deferred Tax Assets | €210.8M | €178.7M |
| Dividends Paid To Equity Holders of Parent Classified As Financing Activities | €575.7M | €547.0M |
| Dividends Paid To Noncontrolling Interests Classified As Financing Activities | €300.0K | €0 |
| Effect of Exchange Rate Changes On Cash and Cash Equivalents | -€62.3M | €13.6M |
| Equity and Liabilities | €17.59B | €16.07B |
| Finance Income | €75.7M | €103.0M |
| Gains Losses On Exchange Differences On Translation Recognised In Profit Or Loss | -€25.2M | -€13.9M |
| Income Tax Relating To Components of Other Comprehensive Income That Will Be Reclassified To Profit Or Loss | €0 | -€4.7M |
| Income Tax Relating To Remeasurements of Defined Benefit Plans of Other Comprehensive Income | €4.0M | €300.0K |
| Income Taxes Paid Refund Classified As Operating Activities | €432.2M | €437.0M |
| Increase Decrease In Cash and Cash Equivalents | €300.5M | -€734.7M |
| Increase Decrease Through Changes In Ownership Interests In Subsidiaries That Do Not Result In Loss of Control | -€210.9M | -€51.9M |
| Increase Decrease Through Sharebased Payment Transactions | €38.3M | €37.7M |
| Increase Decrease Through Treasury Share Transactions | -€111.2M | €113.7M |
| Intangible Assets Other Than Goodwill | €2.59B | €2.64B |
| Interest Paid Classified As Operating Activities | €106.6M | €91.7M |
| Investment Accounted For Using Equity Method | €0 | €0 |
| Issue of Equity | €0 | €0 |
| Issued Capital | €1.05B | €1.05B |
| Noncurrent Investments In Equity Instruments Designated At Fair Value Through Other Comprehensive Income | €27.2M | €43.0M |
| Noncurrent Provisions For Employee Benefits | €125.3M | €137.6M |
| Other Adjustments For Noncash Items | €11.3M | €7.8M |
| Other Comprehensive Income | -€707.5M | €252.0M |
| Other Comprehensive Income Before Tax Cash Flow Hedges | -€10.3M | -€12.9M |
| Other Comprehensive Income Before Tax Exchange Differences On Translation | -€676.1M | €259.9M |
| Other Comprehensive Income Before Tax Gains Losses On Remeasurements of Defined Benefit Plans | €15.8M | €1.0M |
| Other Current Financial Assets | €800.0K | €1.3M |
| Other Current Financial Liabilities | €100.0K | €400.0K |
| Other Longterm Provisions | €177.9M | €167.1M |
| Other Noncurrent Assets | €187.2M | €142.4M |
| Other Operating Income Expense | -€152.3M | -€139.7M |
| Payments For Debt Issue Costs | €15.7M | €15.4M |
| Payments From Changes In Ownership Interests In Subsidiaries | €26.7M | €20.3M |
| Payments To Acquire Or Redeem Entitys Shares | €111.2M | €46.3M |
| Proceeds From Issuing Shares | €0 | €0 |
| Proceeds From Noncurrent Borrowings | €1.55B | €801.5M |
| Research and Development Expense | €409.3M | €406.1M |
| Reserve of Exchange Differences On Translation | -€874.5M | -€198.5M |
| Selling General and Administrative Expense | €2.45B | €2.28B |
| Share Issue Related Cost | €600.0K | €0 |
| Share of Profit Loss of Associates Accounted For Using Equity Method | €0 | €0 |
| Trade and Other Payables To Trade Suppliers | €1.06B | €963.6M |
Methodology
Every line item above is a fact tagged in LEGRAND's annual report
filed in the European Single Electronic Format (ESEF) under the IFRS
taxonomy (ifrs-full) — the income statement, balance sheet
and cash-flow statement as the filer reported them. Values are shown
as-is, in the reporting currency (EUR), without
rescaling; the row labels map to the underlying concept name (e.g.
Revenue → ifrs-full:Revenue, Operating profit →
ifrs-full:ProfitLossFromOperatingActivities, Diluted EPS →
ifrs-full:DilutedEarningsLossPerShare), and any concept
without a curated label is shown under “Other reported items” with its
de-camel-cased tag name. Only consolidated, default-member facts are
shown (segment / dimensional breakdowns are excluded).
“Derived metrics” (free cash flow, margins, ROE, …) are computed from those facts by the same model the U.S. financials pages use — not tagged by the filer.
Source: machine-readable OIM xBRL-JSON aggregated by filings.xbrl.org (XBRL International). Entity identity is resolved by LEI via the public-domain GLEIF register. This is reference data, not investment advice.